Statement of Financial Position (USD $)	Aug. 31, 2012	Feb. 28, 2012
Current assets
Cash and cash equivalents	$ 65,172	$ 258,140
Investment in Apricus Biosciences, Inc.	1,000,000	0
Accounts receivable, net of reserves	65,708	106,635
Inventories, net of reserve for obsolescence	0	2,169
Prepaid expenses	14,594	17,349
Total current assets	1,145,474	384,293
Intangible assets, net of accumulated amortization	698,899	743,040
Security deposits	992	992
Total assets	1,845,365	1,128,325
Current liabilities
Accounts payable and accrued liabilities	389,190	382,960
Promissory notes	500,000	500,000
Total liabilities	889,190	882,960
Stockholders' equity
Capital stock Authorized 150,000,000 common shares, par value $0.0001 Issued and outstanding February 28, 2012 - 20,836,000 common shares August 31, 2012 - 20,836,000 common shares	2,084	2,084
Additional paid-in capital	2,626,745	2,494,607
Deficit accumulated during the development stage	(1,672,654)	(2,251,326)
Total stockholders' equity	956,175	245,365
Total liabilities and stockholders' equity	$ 1,845,365	$ 1,128,325